Login
Super Investors / AIGH Capital Management LLC
AC

AIGH Capital Management LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$1.59B
Positions
45
Quarter ended
June 30, 2026
Filed
August 07, 2026

Reported portfolio value by quarter (23 quarters reported)

$1.59B $211M
Q4 20 Q1 22 Q2 23 Q3 24 Q4 25 Q2 26

$246M in Q4 2020 → $1.59B now. Hover for any quarter.

Holdings

As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Sandisk Corp 21.4% Trimmed 26% 149,000 $339M
IT Ishares Tr Put 20.9% Added 84% 1,103,000 $331M
IQ Invesco Qqq Tr Put 8.9% New 192,500 $142M
Maxlinear Inc 6.6% New 818,000 $105M
Intel Corp 5.5% New 623,500 $87.1M
Digital Turbine Inc 5.3% Added 34% 6,548,450 $84.5M
Silicon Motion Technology Co 3.0% Trimmed 28% 144,000 $48M
Clearfield Inc 2.5% New 1,008,469 $40.1M
ME Methode Electrs Inc 2.0% New 1,678,409 $31.8M
AS Amtech Sys Inc 1.8% New 1,252,000 $28.9M
Fennec Pharmaceuticals Inc 1.7% Added 25% 2,486,038 $26.7M
Kyverna Therapeutics Inc 1.6% Added 40% 2,795,797 $24.9M
NS Nyxoah S A 1.5% New 14,534,880 $24.6M
Personalis Inc 1.4% Trimmed 41% 1,715,000 $23M
Sophia Genetics Sa 1.4% New 3,954,194 $22.8M
3S 3d Sys Corp Del 1.4% New 7,271,000 $22M
Vuzix Corp 1.2% Added 105% 6,745,667 $19.6M
Abeona Therapeutics Inc 1.2% Trimmed 3.6% 2,987,000 $18.5M
Ardelyx Inc 1.0% New 3,200,000 $16.3M
Biodesix Inc 1.0% Trimmed 11% 678,328 $15.3M
Spruce Biosciences Inc 0.9% New 250,000 $13.5M
Castle Biosciences Inc 0.8% Trimmed 7.7% 545,101 $13M
Vanda Pharmaceuticals Inc 0.8% Trimmed 26% 2,044,169 $12.5M
Pelthos Therapeutics Inc 0.6% New 329,098 $9.3M
Domo Inc Call 0.6% New 2,880,000 $9.01M
Polypid Ltd 0.5% Trimmed 5.6% 1,504,741 $7.64M
Verastem Inc 0.5% Trimmed 3.7% 1,927,000 $7.36M
Broadwind Inc 0.4% New 1,156,000 $5.58M
Aeye Inc 0.3% New 3,855,000 $5.55M
Orthopediatrics Corp 0.3% New 269,765 $5.16M
Apyx Medical Corporation 0.3% Added 2.1% 1,128,343 $5.07M
IP Ideal Pwr Inc 0.3% Trimmed 24% 894,731 $4.8M
Talphera Inc 0.3% Trimmed 1.3% 4,601,502 $4.74M
Tigo Energy Inc 0.3% Trimmed 73% 1,990,371 $4.64M
Energous Corp 0.3% Trimmed 15% 182,000 $4.38M
Renovorx Inc 0.3% Added 19% 4,405,439 $4.32M
RE Richardson Electrs Ltd 0.2% New 200,434 $3.81M
Neuraxis Inc 0.2% Added 30% 519,938 $3.8M
Coya Therapeutics Inc 0.2% Trimmed 35% 631,912 $3.7M
Identiv Inc 0.2% Added 254% 1,449,121 $3.65M
Elutia Inc 0.2% Trimmed 25% 2,695,644 $2.64M
Aprea Therapeutics Inc 0.1% Unchanged 1,015,541 $815K
Biofrontera Inc 0.0% Trimmed 19% 739,910 $700K
Quoin Pharmaceuticals Ltd 0.0% Added 37% 70,000 $339K
Nn Inc 0.0% New 11,496 $41.3K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q2 2026

quarter ended June 30, 2026 · filed August 07, 2026

Company Action Shares changed Value of change % of portfolio
IT Ishares Tr Added +503,000 +$151M 20.9%
IQ Invesco Qqq Tr New +192,500 +$142M 8.9%
Sandisk Corp Trimmed −51,000 −$116M 21.4%
Maxlinear Inc New +818,000 +$105M 6.6%
Intel Corp New +623,500 +$87.1M 5.5%
Zoom Communications Inc Exited −700,000 −$56.3M
Clearfield Inc New +1,008,469 +$40.1M 2.5%
SS Select Sector SPDR Tr Exited −300,000 −$39.9M
ME Methode Electrs Inc New +1,678,409 +$31.8M 2.0%
AS Amtech Sys Inc New +1,252,000 +$28.9M 1.8%

Showing the 10 largest of 60 changes.

Q1 2026

quarter ended March 31, 2026 · filed April 30, 2026

Company Action Shares changed Value of change % of portfolio
IT Ishares Tr New +600,000 +$149M 20.3%
Zoom Communications Inc Exited −700,000 −$60.4M
Zoom Communications Inc New +700,000 +$56.3M 7.7%
Sandisk Corp Trimmed −80,000 −$50.8M 17.3%
SS Select Sector SPDR Tr New +300,000 +$39.9M 5.4%
Tigo Energy Inc New +7,280,312 +$27.4M 3.7%
Silicon Motion Technology Co New +200,000 +$22.5M 3.1%
ZT Zebra Technologies Corporati New +100,000 +$20.9M 2.9%
Day One Biopharmaceuticals Exited −1,992,021 −$18.6M
GH Generac Hldgs Inc New +90,000 +$17.6M 2.4%

Showing the 10 largest of 46 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 02, 2026

Company Action Shares changed Value of change % of portfolio
ST Seagate Technology Hldngs Trimmed −12,450,132 −$3.43B 1.3%
Zoom Communications Inc New +700,000 +$60.4M 14.6%
Maxlinear Inc Exited −1,107,504 −$17.8M
Vanda Pharmaceuticals Inc New +1,998,431 +$17.6M 4.3%
Lumen Technologies Inc Exited −2,550,000 −$15.6M
Kyverna Therapeutics Inc New +1,500,000 +$14.1M 3.4%
C Corning Inc Exited −3,829,453 −$12.3M
Zevra Therapeutics Inc Exited −1,231,932 −$11.7M
Mobileye Global Inc Exited −4,423,008 −$11.3M
Abeona Therapeutics Inc New +2,000,000 +$10.5M 2.6%

Showing the 10 largest of 43 changes.

Q3 2025

quarter ended September 30, 2025 · filed October 31, 2025

Company Action Shares changed Value of change % of portfolio
ST Seagate Technology Hldngs Pl New +12,470,132 +$37.9M 10.7%
Sandisk Corp New +280,000 +$31.4M 8.9%
Lightpath Technologies Inc Trimmed −2,742,377 −$21.7M 2.0%
Maxlinear Inc New +1,107,504 +$17.8M 5.0%
Castle Biosciences Inc New +707,287 +$16.1M 4.5%
Lumen Technologies Inc New +2,550,000 +$15.6M 4.4%
Scpharmaceuticals Inc Exited −3,867,523 −$14.7M
C Corning Inc Added +3,654,453 +$11.8M 3.5%
Electrovaya Inc Trimmed −1,963,736 −$11.6M 0.3%
Mobileye Global Inc New +4,423,008 +$11.3M 3.2%

Showing the 10 largest of 48 changes.

Q2 2025

quarter ended June 30, 2025 · filed July 29, 2025

Company Action Shares changed Value of change % of portfolio
IQ Invesco Qqq Tr Exited −70,000 −$32.8M
Nlight Inc New +600,103 +$11.8M 5.3%
Bk Technologies Corporation Exited −268,180 −$10.5M
Domo Inc Added +589,935 +$8.24M 8.4%
IT Ishares Tr Exited −40,000 −$7.98M
Intellicheck Inc Trimmed −1,443,364 −$7.78M 0.4%
Allient Inc New +200,000 +$7.26M 3.3%
Akebia Therapeutics Inc Exited −2,925,000 −$5.62M
Zevra Therapeutics Inc Trimmed −519,216 −$4.57M 3.6%
Vishay Precision Group Inc Added +159,919 +$4.49M 5.4%

Showing the 10 largest of 38 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 06, 2025

Company Action Shares changed Value of change % of portfolio
IQ Invesco Qqq Tr New +70,000 +$32.8M 13.6%
C Corning Inc Trimmed −500,000 −$22.9M 3.3%
Marvell Technology Inc Exited −200,000 −$22.1M
Marvell Technology Inc Exited −150,000 −$16.6M
DS Delcath Sys Inc Trimmed −1,124,670 −$14.3M 1.4%
Tarsus Pharmaceuticals Inc Exited −224,713 −$12.4M
Xeris Biopharma Holdings Inc Exited −2,574,846 −$8.73M
IT Ishares Tr New +40,000 +$7.98M 3.3%
Vishay Precision Group Inc New +263,565 +$6.35M 2.6%
Heron Therapeutics Inc New +2,778,200 +$6.11M 2.5%

Showing the 10 largest of 48 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 12, 2025

Company Action Shares changed Value of change % of portfolio
SS SPDR Ser Tr Exited −500,000 −$110M
Marvell Technology Inc New +200,000 +$22.1M 6.9%
Marvell Technology Inc New +150,000 +$16.6M 5.2%
Digital Turbine Inc Exited −4,490,140 −$13.8M
Verastem Inc New +2,665,043 +$13.8M 4.3%
Backblaze Inc New +1,800,000 +$10.8M 3.4%
C Corning Inc Trimmed −150,000 −$7.13M 1.1%
Cellectar Biosciences Inc Exited −3,197,394 −$6.84M
Zevra Therapeutics Inc New +788,614 +$6.58M 2.1%
DS Delcath Sys Inc Trimmed −397,101 −$4.78M 5.2%

Showing the 10 largest of 39 changes.

Q3 2024

quarter ended September 30, 2024 · filed November 13, 2024

Company Action Shares changed Value of change % of portfolio
SS SPDR Ser Tr Trimmed −500,000 −$110M 31.2%
C Corning Inc New +675,000 +$30.5M 8.6%
Western Digital Corp. Exited −300,000 −$22.7M
Silicon Motion Technology Co Exited −275,000 −$22.3M
Personalis Inc New +3,999,064 +$21.5M 6.1%
Infinera Corp Exited −3,368,556 −$20.5M
Digital Turbine Inc New +4,490,140 +$13.8M 3.9%
C Corning Inc New +225,000 +$10.2M 2.9%
Tarsus Pharmaceuticals Inc New +204,413 +$6.72M 1.9%
Xeris Biopharma Holdings Inc New +2,185,654 +$6.23M 1.8%

Showing the 10 largest of 37 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support